Visualization of the two-step fusion process of the retrovirus avian sarcoma/leukosis virus by cryo-electron tomography

Journal of Virology

Volumn 86, Issue 22, 2012, Pages 12129-12137

  Cardone, Giovanni ^a,c   Brecher, Matthew ^b,d   Fontana, Juan ^a   Winkler, Dennis C ^a   Butan, Carmen ^a,e   White, Judith M ^b   Steven, Alasdair C ^a  

^a NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d NEW YORK STATE DEPARTMENT OF HEALTH   (United States)

^e HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIPOSOME; VIRUS RECEPTOR;

ARTICLE; AVIAN SARCOMA VIRUS; ELECTRON TOMOGRAPHY; LEUKEMIA VIRUS; MEMBRANE FUSION; NONHUMAN; PH; PRIORITY JOURNAL; RECEPTOR BINDING; TEMPERATURE; VIRION; VIRION RECEPTOR LIPOSOME COMPLEX; VIRUS CELL INTERACTION; VIRUS ENTRY; VIRUS ENVELOPE; VIRUS MORPHOLOGY; VIRUS PARTICLE;

ALPHARETROVIRUS; ANIMALS; CELL LINE; CHICKENS; COMPUTER SIMULATION; CRYOELECTRON MICROSCOPY; ELECTRON MICROSCOPE TOMOGRAPHY; FIBROBLASTS; FLUORESCENCE RESONANCE ENERGY TRANSFER; GLYCOPROTEINS; HYDROGEN-ION CONCENTRATION; IMAGE PROCESSING, COMPUTER-ASSISTED; LIPOSOMES; MEMBRANE FUSION; PROTEIN BINDING; RETROVIRIDAE; VIRAL ENVELOPE PROTEINS;

AVES; MIRIDAE;

EID: 84869120630     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01880-12     Document Type: Article

References (55)

1. Barber CB, et al. 2012. Geometry: mesh generation and surface tesselation.R package version 0.3-0. R Development Core Team, Vienna, Austria.
2. Butan C, et al. 2010. Suppression of a morphogenic mutant in Rous sarcoma virus capsid protein by a second-site mutation: a cryo-electron tomography study. J. Virol. 84:6377-6386.
3. Butan C, Winkler DC, Heymann JB, Craven RC, Steven AC. 2008. RSV capsid polymorphism correlates with polymerization efficiency and envelope glycoprotein content: implications that nucleation controls morphogenesis. J. Mol. Biol. 376:1168-1181.
4. Cardone G, Grünewald K, Steven AC. 2005. A resolution criterion for electron tomography based on cross-validation. J. Struct. Biol. 151:117-129.
5. Clark PJ, Evans FC. 1954. Distance to nearest neighbor as a measure of spatial relationships in populations. Ecology 35:445-453.
6. Clark PJ, Evans FC. 1979. Generalization of a nearest neighbor measure of dispersion for use in K-dimensions. Ecology 60:316-317.
7. Connolly SA, Leser GP, Yin HS, Jardetzky TS, Lamb RA. 2006. Refolding of a paramyxovirus F protein from prefusion to postfusion conformations observed by liposome binding and electron microscopy. Proc. Natl.Acad. Sci. U. S. A. 103:17903-17908.
8. Constantine W, Percival D. 2011. Fractal:fractal time series modeling and analysis. R package version 1.1-1. R Development Core Team, Vienna, Austria.
9. Damico RL, Crane J, Bates P. 1998. Receptor-triggered membrane association of a model retroviral glycoprotein. Proc. Natl. Acad. Sci. U. S. A.95:2580-2585.
10. Delos SE, et al. 2008. Cysteines flanking the internal fusion peptide are required for the avian sarcoma/leukosis virus glycoprotein to mediate the lipid mixing stage of fusion with high efficiency. J. Virol. 82:3131-3134.
11. Delos SE, Godby JA, White JM. 2005. Receptor-induced conformational changes in the SU subunit of the avian sarcoma/leukosis virus A envelope protein: implications for fusion activation. J. Virol. 79:3488-3499.
12. Delos SE, La B, Gilmartin A, White JM. 2010. Studies of the chain reversal regions of the avian sarcoma/leukosis virus (ASLV) and Ebolavirus fusion proteins: analogous residues are important, and a His residue unique to EnvA affects the pH dependence of ASLV entry. J. Virol. 84:5687-5694.
13. Earp LJ, Delos SE, Netter RC, Bates P, White JM. 2003. The avian retrovirus avian sarcoma/leukosis virus subtype A reaches the lipid mixing stage of fusion at neutral pH. J. Virol. 77:3058-3066.
14. Feng D, Tierney L. 2008. Computing and displaying isosurfaces in R. J.Stat. Softw. 28:1-24
15. Fontana J, Cardone G, Heymann JB, Winkler DC, Steven AC. 2012.Structural changes in influenza virus at low pH characterized by cryoelectron tomography. J. Virol. 86:2919-2929.
16. Frangakis AS, Hegerl R. 2001. Noise reduction in electron tomographic reconstructions using nonlinear anisotropic diffusion. J. Struct. Biol. 135: 239-250.
17. Furuta RA, Wild CT, Weng Y, Weiss CD. 1998. Capture of an early fusion-active conformation of HIV-1 gp41. Nat. Struct. Biol. 5:276-279.
18. Gilbert JM, Hernandez LD, Balliet JW, Bates P, White JM. 1995. Receptor-induced conformational changes in the subgroup A avian leukosis and sarcoma virus envelope glycoprotein. J. Virol. 69:7410-7415.
19. Grünewald K, et al. 2003. Three-dimensional structure of herpes simplex virus from cryo-electron tomography. Science 302:1396-1398.
20. Harrison SC. 2008. Viral membrane fusion. Nat. Struct. Mol. Biol. 15:690-698.
21. Hernandez LD, et al. 1997. Activation of a retroviral membrane fusion protein: soluble receptor-induced liposome binding of the ASLV envelope glycoprotein. J. Cell Biol. 139:1455-1464
22. Heymann JB, Cardone G, Winkler DC, Steven AC. 2008. Computational resources for cryo-electron tomography in Bsoft. J. Struct. Biol.161:232-242.
23. Jiang S, Lin K, Strick N, Neurath AR. 1993. HIV-1 inhibition by a peptide. Nature 365:113.
24. Jiang W, Baker ML, Wu Q, Bajaj C, Chiu W. 2003. Applications of a bilateral deionising filter in biological electron microscopy. J. Struct. Biol. 144:114-122.
25. Jun S, et al. 2011. Direct visualization of HIV-1 with correlative live-cellmicroscopy and cryo-electron tomography. Structure 19:1573-1581.
26. Kielian M. 2006. Class II virus membrane fusion proteins. Virology 344:38-47.
27. Kim YH, et al. 2011. Capture and imaging of a prehairpin fusion intermediate of the paramyxovirus PIV5. Proc. Natl. Acad. Sci. U. S. A. 108:20992-20997.
28. Kremer JR, Mastronarde DN, McIntosh JR. 1996. Computer visualization of three-dimensional image data using IMOD. J. Struct. Biol. 116:71-76.
29. Lee KK. 2010. Architecture of a nascent viral fusion pore. EMBO J. 29:1299-1311.
30. Lee KK, et al. 2011. Capturing a fusion intermediate of influenza hemagglutini with a cholesterol-conjugated peptide, a new antiviral strategy for influenza virus. J. Biol. Chem. 286:42141-42149.
31. Libersou S, et al. 2010. Distinct structural rearrangements of the VSV glycoprotein drive membrane fusion. J. Cell Biol. 191:199-210
32. Loving R, Wu SR, Sjoberg M, Lindqvist B, Garoff H. 2012. Maturation cleavage of the murine leukemia virus Env precursor separates the transmembrane subunits to prime it for receptor triggering. Proc. Natl. Acad.Sci. U. S. A. 109:7735-7740.
33. Magnus C, Rusert P, Bonhoeffer S, Trkola A, Regoes RR. 2009. Estimating the stoichiometry of human immunodeficiency virus entry. J. Virol.83:1523-1531.
34. Mastronarde DN. 2005. Automated electron microscope tomography using robust prediction of specimen movements. J. Struct. Biol. 152:36-51
35. Matsuyama S, Delos SE, White JM. 2004. Sequential roles of receptor binding and low pH in forming prehairpin and hairpin conformations of a retroviral envelope glycoprotein. J. Virol. 78:8201-8209.
36. Maurer UE, Sodeik B, GrÜnewald K. 2008. Native 3D intermediates of membrane fusion in herpes simplex virus 1 entry. Proc. Natl. Acad. Sci.U. S. A. 105:10559-10564.
37. Medinas RJ, Lambert DM, Tompkins WA. 2002. C-terminal gp40 peptide analogs inhibit feline immunodeficiency virus: cell fusion and virus spread. J. Virol. 76:9079-9086.
38. Melikyan GB, Barnard RJ, Abrahamyan LG, Mothes W, Young JA.2005. Imaging individual retroviral fusion events: from hemifusion to pore formation and growth. Proc. Natl. Acad. Sci. U. S. A. 102:8728-8733.
39. Mothes W, Boerger AL, Narayan S, Cunningham JM, Young JA. 2000.Retroviral entry mediated by receptor priming and lowpHtriggering of an envelope glycoprotein. Cell 103:679-689.
40. Narayan S, Barnard RJ, Young JA. 2003. Two retroviral entry pathways distinguished by lipid raft association of the viral receptor and differencesin viral infectivity. J. Virol. 77:1977-1983.
41. Narayan S, Young JA. 2004. Reconstitution of retroviral fusion and uncoating in a cell-free system. Proc. Natl. Acad. Sci. U. S. A. 101:7721-7726.
42. Netter RC, et al. 2004. Heptad repeat 2-based peptides inhibit avian sarcoma and leukosis virus subgroup a infection and identify a fusion intermediate. J. Virol. 78:13430-13439.
43. Padilla-Parra S, Marin M, Kondo N, Melikyan GB. 2012. Synchronized retrovirus fusion in cells expressing alternative receptor isoforms releases the viral core into distinct sub-cellular compartments. PLoS Pathog.8:e1002694. doi:10.1371/journal.ppat.1002694.
44. Puri A, Booy FP, Doms RW, White JM, Blumenthal R. 1990. Conformational changes and fusion activity of influenza virus hemagglutinin of the H2 and H3 subtypes: effects of acid pretreatment. J. Virol. 64:3824-3832.
45. R Development Core Team. 2012. R: a language and environment for statistical computing. R Development Core Team, Vienna, Austria.
46. Radermacher M, Wagenknecht T, Verschoor A, Frank J. 1986. A new 3-D reconstruction scheme applied to the 50S ribosomal subunit of E. coli.J. Microsc. 141:RP1-RP2.
47. Renka RJ, Gebhardt A, Eglen S, Zuyev S, White D. 2009. Tripack:triangulation of irregularly spaced data. R package version 1.3-4. R Developmen Core Team, Vienna, Austria.
48. Russell CJ, Jardetzky TS, Lamb RA. 2001. Membrane fusion machines of paramyxoviruses: capture of intermediates of fusion. EMBO J. 20:4024-4034.
49. Saxton WO, Baumeister W. 1982. The correlation averaging of a regularly arranged bacterial cell envelope protein. J. Microsc. 127:127-138.
50. Scheres SH, Melero R, Valle M, Carazo JM. 2009. Averaging of electron subtomograms and random conical tilt reconstructions through likelihood optimization. Structure 17:1563-1572.
51. Smith JG, Mothes W, Blacklow SC, Cunningham JM. 2004. The mature avian leukosis virus subgroup A envelope glycoprotein is metastable, and refolding induced by the synergistic effects of receptor binding and lowpH is coupled to infection. J. Virol. 78:1403-1410.
52. Tonelli M, Peters RJ, James TL, Agard DA. 2001. The solution structure of the viral binding domain of Tva, the cellular receptor for subgroup A avian leukosis and sarcoma virus. FEBS Lett. 509:161-168.
53. White JM, Delos SE, Brecher M, Schornberg K. 2008. Structures and mechanisms of viral membrane fusion proteins: multiple variations on a common theme. Crit. Rev. Biochem. Mol. Biol. 43:189-219.
54. Wild CT, Shugars DC, Greenwell TK, McDanal CB, Matthews TJ. 1994.Peptides corresponding to a predictive alpha-helical domain of human immunodeficiency virus type 1 gp41 are potent inhibitors of virus infection.Proc. Natl. Acad. Sci. U. S. A. 91:9770-9774.
55. Wu SR, et al. 2008. Turning of the receptor-binding domains opens upthe murine leukaemia virus Env for membrane fusion. EMBO J. 27:2799-2808.